fingolimod hydrochloride has been researched along with Mesothelioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbone, M; Furuya, H; Gaudino, G; Giorgi, C; Larson, D; Li, S; Napolitano, A; Pass, HI; Pastorino, S; Pellegrini, L; Pinton, P; Szymiczek, A; Takinishi, Y; Tanji, M; Xue, J; Yang, H | 1 |
1 other study(ies) available for fingolimod hydrochloride and Mesothelioma
| Article | Year |
|---|---|
FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Fingolimod Hydrochloride; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice; Protein Phosphatase 2; Tumor Suppressor Proteins | 2017 |